Advertisement

Topics

Latest "Acton Research Corporation" News Stories

18:29 EST 17th December 2017 | BioPortfolio

Here are the most relevant search results for "Acton Research Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Acton Research Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Acton Research Corporation for you to read. Along with our medical data and news we also list Acton Research Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Acton Research Corporation Companies for you to search.

Showing "Acton Research Corporation" News Articles 1–25 of 26,000+

Relevant

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, reminds its shareholders to vote “FOR” the proposed merger with Invitae Corporation as described in the Company’s proxy statement/prospectus fo...


CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announced today that, based upon the final vote count for the Company’s Special Meeting of Stockholders held today, a majority of its stockholders ...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, today announced that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have both recommended that CombiMatr...


Orion Corporation: Managers' transactions - Hilpi Rautelin

ORION CORPORATION      MANAGERS' TRANSACTIONS 1st of November 2017 at 22.15 EET              Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their ...

Insulet breaks ground on Mass. manufacturing facility

Insulet started construction on its 300,000-square-foot manufacturing facility in Acton, Mass., which will include an innovat -More- 

BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD -- (Marketwired) -- 08/08/17 -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 the shareholders re-elected Dr. George Adams, Mr. Danny Dalla-Longa, Dr. Alan Rabinowitz, Dr. Don Segal and Mr. David Willis as Directors of the Corporation. They further approved the Incentive Stock ...

Hydropothecary Announces Bought Deal Offering to be Extended to Quebec

GATINEAU, QC--(Marketwired - November 02, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) announced today that its previously announced bought deal offering of 60,000 convertible debenture units of the Company for aggre...

Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation

EAST RUTHERFORD, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Gregory B. Brown, M.D. was appointed to the Company’s Board of Directors on October 31, 2017, and will serve on the Board’s Audit and Regulatory Affairs Committees.  Dr. Brown...

Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm

REHOVOT, Israel, Oct. 18, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced today the completion of the previously announced acquisition of NeuroDerm by Mitsubishi Tanabe Pharma Corporation (TSE Code: 4508), a publicly traded company on the Tokyo Stock Exchang...

Geron Corporation Reports Third Quarter 2017 Financial Results

MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2017. For the third quarter of 2017, the company reported a net loss of $6.9 million, or $0.04 per share, compared to $3.6 million, or $0.02 per share, for the comparable 2016 period. Net loss for the first nine months o...

CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results

IRVINE, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces financial and operating results for the three and nine months ended September 30, 2017. 

ICC International Cannabis Corporation Provides Cannabinoid Extract Business Segment Update

Highlights:

Hydropothecary Announces Stock Option Grants to Officers and Employees

GATINEAU, QC--(Marketwired - September 08, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) announces that it has made a grant of stock options under its stock option plan to certain of its officers to acquire a total of 650,000 common shares of the Company. In addition, the Company has granted options to acquire an aggregate of 1,000 common shares of the Compan...

Hydropothecary Announces Stock Option Grants to Directors and Employees

GATINEAU, QC--(Marketwired - November 06, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) announces that it has made a grant of stock options under its stock option plan to certain of its directors to acquire a total of 125,000 common shares of the Company. In addition, the Company has granted options to acquire an aggregate of 3,000 common shares of the Compan...

Prothena to Report Third Quarter 2017 Financial Results on November 7

DUBLIN, Ireland, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, will announce financial results for the third quarter and first nine months of 2017 on November 7, 2017 after the close of the U.S. financial markets. Consistent wit...

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced that at NeuroDerm’s extraordinary general meeting of shareholders held today, NeuroDerm shareholders voted to approve the previously announced acquisition by Mitsubishi Tanabe Pharm...

International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease

CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products reported today that a third patient of the second cohort with Parkinson's disease was successfully trans...

Orthobond Corporation to Present at the 2017 North American Spine Society Annual Meeting

NORTH BRUNSWICK, N.J., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Orthobond Corporation (North Brunswick, NJ), a leader in the design and development of antimicrobial implant surfaces, has been invited to participate in a focused session on occult infections in the spine at the 2017 North American Spine Society (NASS) Annual Meeting. The annual NASS meeting is the largest gathering of spine surgeons i...

Stryker increases dividend 11%, declaring a $0.47 per share quarterly dividend

Kalamazoo, Michigan - December 6, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record at the close of business on December 29, 2017, representing an increase of approximately 11% versus the prior year and the previous quarter.  "Our financial st...

VWR Corporation to Report Third Quarter 2017 Results on November 7, 2017

RADNOR, Pa., October 26, 2017 -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, today announced that it will release its third quarter 2017 financial results on Tuesday, November 7, 2017, before the market opens. Previously, VWR announced that it had entered into a definitive agreement with ...

International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017

CARLSBAD, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced operating results for the three and nine months ending o...

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease

CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two more patients with Parkinson’s disease were successfully transplanted with ISCO’s proprietary ISC-hpNSC® cells at the Royal Melbourne Hospital (R...

International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial

CARLSBAD, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the completion of its preclinical studies in Traumatic Brain Injury (TBI) program will po...

AntriaBio Announces Exclusive License Agreement for a Phase 2 Orphan Disease Therapy with XOMA Corporation and Name Change to Rezolute, Inc.

LOUISVILLE, Colo., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or the “Company”) (OTCQB:ANTB), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for metabolic and orphan diseases, and XOMA Corporation (“XOMA”) (NASDAQ:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, announ...


Quick Search
Advertisement
 

News Quicklinks